Global Recombinant Technology Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS11018 | Category: Healthcare | Pages: 129 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Recombinant Technology, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Technology.

The Recombinant Technology market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Recombinant Technology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Technology manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Recombinant Technology market size in 2022 is 734032.8 million US dollars, and it is expected to be 1127250.0 million US dollars by 2029, with a compound annual growth rate of 6.32% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Recombinant Technology market include Amgen Inc (U.S.), Novartis AG (Germany), Novo Nordisk A/S (Denmark), Sanofi (France), and Merck & Co., Inc. (U.S.). The share of the top 3 players in the Recombinant Technology market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Recombinant Technology market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Medical accounted for XX% of Recombinant Technology market in 2022. Therapeutic Agent share of XX%.
Food and Agriculture accounted for XX% of the Recombinant Technology market in 2022. Health and Disease accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Recombinant Technology market status and forecast by region.
Chapters 2-3: Segmented the global Recombinant Technology market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Recombinant Technology market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Recombinant Technology market country segmentation data.
Chapter 10: Analyzes the main companies in the Recombinant Technology industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Amgen Inc (U.S.)
Novartis AG (Germany)
Novo Nordisk A/S (Denmark)
Sanofi (France)
Merck & Co., Inc. (U.S.)
Genentech, Inc. (U.S.)
GenScript (U.S.)
Pfizer Inc. (U.S.)
Biocon (India)
GlaxoSmithKline plc. (U.K.)
New England Biolabs (U.K.) Ltd. (U.K.)
Cibus (U.S.)
Horizon Discovery Ltd. (U.K.)
Boehringer Ingelheim International GmbH (Germany)
Thermo Fisher Scientific Inc. (U.S.)

Types list
Medical
Therapeutic Agent
Human Protein
Vaccines
Non-Medical
Biotech Crops
Specialty Chemicals
Others

Application list
Food and Agriculture
Health and Disease
Environment
Others

Table of Content

1 Recombinant Technology Market Overview
1.1 Recombinant Technology Product Overview
1.1.1 Recombinant Technology Product Scope
1.1.2 Recombinant Technology Market Status and Outlook
1.2 Global Recombinant Technology Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Recombinant Technology Market Size by Region (2018-2029)
1.4 Global Recombinant Technology Historic Market Size by Region (2018-2023)
1.5 Global Recombinant Technology Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Recombinant Technology Market Size (2018-2029)
1.6.1 North America Recombinant Technology Market Size (2018-2029)
1.6.2 Europe Recombinant Technology Market Size (2018-2029)
1.6.3 Asia-Pacific Recombinant Technology Market Size (2018-2029)
1.6.4 Latin America Recombinant Technology Market Size (2018-2029)
1.6.5 Middle East & Africa Recombinant Technology Market Size (2018-2029)
2 Recombinant Technology Market Overview by Type
2.3 Global Recombinant Technology Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Recombinant Technology Historic Market Size by Type (2018-2023)
2.5 Global Recombinant Technology Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Recombinant Technology Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Recombinant Technology Market Size Breakdown by Type
2.6.3 Asia-Pacific Recombinant Technology Market Size Breakdown by Type
2.6.4 Latin America Recombinant Technology Market Size Breakdown by Type
2.6.5 Middle East and Africa Recombinant Technology Market Size Breakdown by Type
3 Recombinant Technology Market Overview by Application
3.3 Global Recombinant Technology Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Recombinant Technology Historic Market Size by Application (2018-2023)
3.5 Global Recombinant Technology Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Recombinant Technology Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Recombinant Technology Market Size Breakdown by Application
3.6.3 Asia-Pacific Recombinant Technology Market Size Breakdown by Application
3.6.4 Latin America Recombinant Technology Market Size Breakdown by Application
3.6.5 Middle East and Africa Recombinant Technology Market Size Breakdown by Application
4 Recombinant Technology Competition Analysis by Players
4.1 Global Recombinant Technology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Technology as of 2022)
4.3 Date of Key Players Enter into Recombinant Technology Market
4.4 Global Top Players Recombinant Technology Headquarters and Area Served
4.5 Key Players Recombinant Technology Product Solution and Service
4.6 Competitive Status
4.6.1 Recombinant Technology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Recombinant Technology Market Segment by Country
5.1 North America Recombinant Technology Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Recombinant Technology Market Segment by Country
6.1 Europe Recombinant Technology Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Recombinant Technology Market Segment by Country
7.1 Asia-Pacific Recombinant Technology Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Recombinant Technology Market Segment by Country
8.1 Latin America Recombinant Technology Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Recombinant Technology Market Segment by Country
9.1 Middle East & Africa Recombinant Technology Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Amgen Inc (U.S.)
10.1.1 Amgen Inc (U.S.) Information
10.1.2 Business Overview
10.1.3 Amgen Inc (U.S.) Recombinant Technology Revenue, Gross Margin
10.1.4 Recombinant Technology Products Offered
10.1.5 Amgen Inc (U.S.) Recent Development
10.2  Novartis AG (Germany)
10.2.1 Novartis AG (Germany) Information
10.2.2 Business Overview
10.2.3 Novartis AG (Germany) Recombinant Technology Revenue, Gross Margin
10.2.4 Recombinant Technology Products Offered
10.2.5 Novartis AG (Germany) Recent Development
10.3  Novo Nordisk A/S (Denmark)
10.3.1 Novo Nordisk A/S (Denmark) Information
10.3.2 Business Overview
10.3.3 Novo Nordisk A/S (Denmark) Recombinant Technology Revenue, Gross Margin
10.3.4 Recombinant Technology Products Offered
10.3.5 Novo Nordisk A/S (Denmark) Recent Development
10.4  Sanofi (France)
10.4.1 Sanofi (France) Information
10.4.2 Business Overview
10.4.3 Sanofi (France) Recombinant Technology Revenue, Gross Margin
10.4.4 Recombinant Technology Products Offered
10.4.5 Sanofi (France) Recent Development
10.5  Merck & Co., Inc. (U.S.)
10.5.1 Merck & Co., Inc. (U.S.) Information
10.5.2 Business Overview
10.5.3 Merck & Co., Inc. (U.S.) Recombinant Technology Revenue, Gross Margin
10.5.4 Recombinant Technology Products Offered
10.5.5 Merck & Co., Inc. (U.S.) Recent Development
10.6  Genentech, Inc. (U.S.)
10.6.1 Genentech, Inc. (U.S.) Information
10.6.2 Business Overview
10.6.3 Genentech, Inc. (U.S.) Recombinant Technology Revenue, Gross Margin
10.6.4 Recombinant Technology Products Offered
10.6.5 Genentech, Inc. (U.S.) Recent Development
10.7  GenScript (U.S.)
10.7.1 GenScript (U.S.) Information
10.7.2 Business Overview
10.7.3 GenScript (U.S.) Recombinant Technology Revenue, Gross Margin
10.7.4 Recombinant Technology Products Offered
10.7.5 GenScript (U.S.) Recent Development
10.8  Pfizer Inc. (U.S.)
10.8.1 Pfizer Inc. (U.S.) Information
10.8.2 Business Overview
10.8.3 Pfizer Inc. (U.S.) Recombinant Technology Revenue, Gross Margin
10.8.4 Recombinant Technology Products Offered
10.8.5 Pfizer Inc. (U.S.) Recent Development
10.9  Biocon (India)
10.9.1 Biocon (India) Information
10.9.2 Business Overview
10.9.3 Biocon (India) Recombinant Technology Revenue, Gross Margin
10.9.4 Recombinant Technology Products Offered
10.9.5 Biocon (India) Recent Development
10.10  GlaxoSmithKline plc. (U.K.)
10.10.1 GlaxoSmithKline plc. (U.K.) Information
10.10.2 Business Overview
10.10.3 GlaxoSmithKline plc. (U.K.) Recombinant Technology Revenue, Gross Margin
10.10.4 Recombinant Technology Products Offered
10.10.5 GlaxoSmithKline plc. (U.K.) Recent Development
10.11  New England Biolabs (U.K.) Ltd. (U.K.)
10.11.1 New England Biolabs (U.K.) Ltd. (U.K.) Information
10.11.2 Business Overview
10.11.3 New England Biolabs (U.K.) Ltd. (U.K.) Recombinant Technology Revenue, Gross Margin
10.11.4 Recombinant Technology Products Offered
10.11.5 New England Biolabs (U.K.) Ltd. (U.K.) Recent Development
10.12  Cibus (U.S.)
10.12.1 Cibus (U.S.) Information
10.12.2 Business Overview
10.12.3 Cibus (U.S.) Recombinant Technology Revenue, Gross Margin
10.12.4 Recombinant Technology Products Offered
10.12.5 Cibus (U.S.) Recent Development
10.13  Horizon Discovery Ltd. (U.K.)
10.13.1 Horizon Discovery Ltd. (U.K.) Information
10.13.2 Business Overview
10.13.3 Horizon Discovery Ltd. (U.K.) Recombinant Technology Revenue, Gross Margin
10.13.4 Recombinant Technology Products Offered
10.13.5 Horizon Discovery Ltd. (U.K.) Recent Development
10.14  Boehringer Ingelheim International GmbH (Germany)
10.14.1 Boehringer Ingelheim International GmbH (Germany) Information
10.14.2 Business Overview
10.14.3 Boehringer Ingelheim International GmbH (Germany) Recombinant Technology Revenue, Gross Margin
10.14.4 Recombinant Technology Products Offered
10.14.5 Boehringer Ingelheim International GmbH (Germany) Recent Development
10.15  Thermo Fisher Scientific Inc. (U.S.)
10.15.1 Thermo Fisher Scientific Inc. (U.S.) Information
10.15.2 Business Overview
10.15.3 Thermo Fisher Scientific Inc. (U.S.) Recombinant Technology Revenue, Gross Margin
10.15.4 Recombinant Technology Products Offered
10.15.5 Thermo Fisher Scientific Inc. (U.S.) Recent Development
11 Recombinant Technology Market Dynamics
11.1 Recombinant Technology Industry Trends
11.2 Recombinant Technology Growth Drivers
11.3 Recombinant Technology Market Challenges
11.4 Recombinant Technology Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Recombinant Technology Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?